Endocyte is focused on developing targeted therapies that treat cancer and inflammatory diseases. Using proprietary technology, Endocyte creates novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company aims to improve the specificity, safety and efficacy of highly active drugs by targeting them directly to diseased cells. Endocyte is also developing companion diagnostic agents to predict if a patient will respond to its drug therapy. For more information, visit the company’s Web site at www.endocyte.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: